Abstract
The physico-chemical properties of nanoparticles, as characterized under idealized laboratory conditions, have been suggested to differ significantly when studied under complex physiological environments. A major reason for this variation has been the adsorption of biomolecules (mainly proteins) on the nanoparticle surface, constituting the so-called “biomolecular corona”. The formation of biomolecular corona on the nanoparticle surface has been reported to influence various nanoparticle properties viz. cellular targeting, cellular interaction, in vivo clearance, toxicity, etc. Understanding the interaction of nanoparticles with proteins upon administration in vivo thus becomes important for the development of effective nanotechnology-based platforms for biomedical applications. In this chapter, we describe the formation of protein corona on nanoparticles and the differences arising in its composition due to variations in nanoparticle properties. Also discussed is the influence of protein corona on various nanoparticle activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Walczyk D, Bombelli FB, Monopoli MP et al (2010) What the cell “sees” in bionanoscience. JACS 132:5761–5768
Monopoli MP, Åberg C, Salvati A et al (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–786
Raesch SS, Tenzer S, Storck W et al (2015) Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 9:11872–11885
Kapralov AA, Feng WH, Amoscato AA et al (2012) Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 6:4147–4156
Walkey CD, Chan WC (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–2799
Vroman L, Adams A, Fischer G et al (1980) Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55:156–159
Aggarwal P, Hall JB, McLeland CB et al (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437
Vroman L (1962) Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature 196:476–477
Tenzer S, Docter D, Kuharev J et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–781
Gunawan C, Lim M, Marquis CP et al (2014) Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles. J Mater Chem B 2:2060–2083
Maiolo D, Bergese P, Mahon E et al (2014) Surfactant titration of nanoparticle–protein corona. Anal Chem 86:12055–12063
Norde W (1994) Protein adsorption at solid surfaces: a thermodynamic approach. Pure Appl Chem 66:491–496
Saptarshi SR, Duschl A, Lopata AL (2013) Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 11:26
Cedervall T, Lynch I, Lindman S et al (2007) Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 104:2050–2055
Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40–47
Chakraborty S, Joshi P, Shanker V et al (2011) Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir 27:7722–7731
Simberg D, Park J-H, Karmali PP et al (2009) Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 30:3926–3933
Andersson J, Ekdahl KN, Larsson R et al (2002) C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 168:5786–5791
Gagner JE, Lopez MD, Dordick JS et al (2011) Effect of gold nanoparticle morphology on adsorbed protein structure and function. Biomaterials 32:7241–7252
Lundqvist M, Stigler J, Elia G et al (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105:14265–14270
Tenzer S, Docter D, Rosfa S et al (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155–7167
Cedervall T, Lynch I, Foy M et al (2007) Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 46:5754–5756
Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102
Dobrovolskaia MA, Patri AK, Zheng J et al (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed Nanotechnol Biol Med 5:106–117
Deng ZJ, Mortimer G, Schiller T et al (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20:455101
Lacerda SHDP, Park JJ, Meuse C et al (2009) Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4:365–379
Gessner A, Lieske A, Paulke BR et al (2003) Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 65:319–326
Treuel L, Brandholt S, Maffre P et al (2014) Impact of protein modification on the protein corona on nanoparticles and nanoparticle–cell interactions. ACS Nano 8:503–513
Maffre P, Nienhaus K, Amin F et al (2011) Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J Nanotechnol 2:374–383
Gessner A, Lieske A, Paulke BR et al (2002) Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54:165–170
Roser M, Fischer D, Kissel T (1998) Surface-modified biodegradable albumin nano-and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 46:255–263
Lück M, Paulke BR, Schröder W et al (1998) Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. J Biomed Mater Res A 39:478–485
Gessner A, Waicz R, Lieske A et al (2000) Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm 196:245–249
Müller RH, Wallis KH, Troester SD et al (1992) In vitro characterization of poly (methyl-methaerylate) nanoparticles and correlation to their in vivo fate. J Control Release 20:237–246
Monopoli MP, Walczyk D, Campbell A et al (2011) Physical− chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. JACS 133:2525–2534
Maiorano G, Sabella S, Sorce B et al (2010) Effects of cell culture media on the dynamic formation of protein− nanoparticle complexes and influence on the cellular response. ACS Nano 4:7481–7491
Dell'Orco D, Lundqvist M, Oslakovic C et al (2010) Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 5:e10949
Green R, Davies M, Roberts C et al (1999) Competitive protein adsorption as observed by surface plasmon resonance. Biomaterials 20:385–391
Nagayama S, Ogawara K, Fukuoka Y et al (2007) Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm 342:215–221
Casals E, Pfaller T, Duschl A et al (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4:3623–3632
Mahmoudi M, Abdelmonem AM, Behzadi S et al (2013) Temperature: the “ignored” factor at the nanobio interface. ACS Nano 7:6555–6562
Mahmoudi M, Lohse SE, Murphy CJ et al (2013) Variation of protein corona composition of gold nanoparticles following plasmonic heating. Nano Lett 14:6–12
Lesniak A, Campbell A, Monopoli MP et al (2010) Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511–9518
Shannahan JH, Fritz KS, Raghavendra AJ et al (2016) From the cover: disease-induced disparities in formation of the nanoparticle-biocorona and the toxicological consequences. Toxicol Sci 152:406–416
Aoyama M, Hata K, Higashisaka K et al (2016) Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes. Biochem Biophys Res Commun 480:690–695
Albanese A, Walkey CD, Olsen JB et al (2014) Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 8:5515–5526
Dai Q, Guo J, Yan Y et al (2017) Cell-conditioned protein coronas on engineered particles influence immune responses. Biomacromolecules 18:431–439
Ghavami M, Saffar S, Emamy BA et al (2013) Plasma concentration gradient influences the protein corona decoration on nanoparticles. RSC Adv 3:1119–1126
Röcker C, Pötzl M, Zhang F et al (2009) A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4:577–580
Rahimi M, Ng E, Bakhtiari K et al (2014) Zeolite nanoparticles for selective sorption of plasma proteins. Sci Rep 5:17259–17259
Corbo C, Molinaro R, Parodi A et al (2016) The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine 11:81–100
Miclăuş T, Beer C, Chevallier J et al (2016) Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro. Nat Commun 7:11770
Lee YK, Choi E-J, Webster TJ et al (2015) Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine 10:97–113
Salvati A, Pitek AS, Monopoli MP et al (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8:137–143
Mahmoudi M, Sheibani S, Milani AS et al (2015) Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomedicine 10:215–226
Tabata Y, Ikada Y (1990) Phagocytosis of polymer microspheres by macrophages. In: New polymer materials, advances in polymer science, vol 94. Springer, Berlin, pp 107–141
Saha K, Rahimi M, Yazdani M et al (2016) Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano 10:4421–4430
Lesniak A, Fenaroli F, Monopoli MP et al (2012) Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845–5857
Schöttler S, Becker G, Winzen S et al (2016) Protein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriers. Nat Nanotechnol 11:372–377
Walkey CD, Olsen JB, Guo H et al (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. JACS 134:2139–2147
Caracciolo G, Palchetti S, Colapicchioni V et al (2015) Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. Langmuir 31:10764–10773
Behzadi S, Serpooshan V, Sakhtianchi R et al (2014) Protein corona change the drug release profile of nanocarriers: the “overlooked” factor at the nanobio interface. Colloids Surf B Biointerfaces 123:143–149
Landgraf L, Christner C, Storck W et al (2015) A plasma protein corona enhances the biocompatibility of Au@ Fe3O4 Janus particles. Biomaterials 68:77–88
Hu W, Peng C, Lv M et al (2011) Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5:3693–3700
Chong Y, Ge C, Yang Z et al (2015) Reduced cytotoxicity of graphene nanosheets mediated by blood-protein coating. ACS Nano 9:5713–5724
Laurent S, Ng E-P, Thirifays C et al (2013) Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. Toxicol Res 2:270–279
Moyano DF, Goldsmith M, Solfiell DJ et al (2012) Nanoparticle hydrophobicity dictates immune response. JACS 134:3965–3967
Linse S, Cabaleiro-Lago C, Xue W-F et al (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A 104:8691–8696
Nel AE, Mädler L, Velegol D et al (2009) Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater 8:543–557
Smith JR, Cicerone MT, Meuse CW (2009) Tertiary structure changes in albumin upon surface adsorption observed via fourier transform infrared spectroscopy. Langmuir 25:4571–4578
Tsai DH, DelRio FW, Keene AM et al (2011) Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. Langmuir 27:2464–2477
Buijs J, Vera CC, Ayala E et al (1999) Conformational stability of adsorbed insulin studied with mass spectrometry and hydrogen exchange. Anal Chem 71:3219–3225
Buijs J, Norde W, Lichtenbelt JWT (1996) Changes in the secondary structure of adsorbed IgG and F (ab ‘) 2 studied by FTIR spectroscopy. Langmuir 12:1605–1613
Buijs J, James WT, Norde W et al (1995) Adsorption of monoclonal IgGs and their F (ab′) 2 fragments onto polymeric surfaces. Colloids Surf B Biointerfaces 5:11–23
Roach P, Farrar D, Perry CC (2005) Interpretation of protein adsorption: surface-induced conformational changes. JACS 127:8168–8173
Aubin-Tam ME, Hamad-Schifferli K (2005) Gold nanoparticle− cytochrome C complexes: the effect of nanoparticle ligand charge on protein structure. Langmuir 21:12080–12084
Norde W, Giacomelli CE (2000) BSA structural changes during homomolecular exchange between the adsorbed and the dissolved states. J Biotechnol 79:259–268
Mahmoudi M, Shokrgozar MA, Sardari S et al (2011) Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 3:1127–1138
Kondo A, Murakami F, Higashitani K (1992) Circular dichroism studies on conformational changes in protein molecules upon adsorption on ultrafine polystyrene particles. Biotechnol Bioeng 40:889–894
Hong R, Fischer NO, Verma A et al (2004) Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. JACS 126:739–743
Zhang D, Neumann O, Wang H et al (2009) Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH. Nano Lett 9:666–671
Prime KL, Whitesides GM (1991) Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces. Science 252:1164
Cao Z, Jiang S (2012) Super-hydrophilic zwitterionic poly (carboxybetaine) and amphiphilic non-ionic poly (ethylene glycol) for stealth nanoparticles. Nano Today 7:404–413
Yang W, Zhang L, Wang S et al (2009) Functionalizable and ultra stable nanoparticles coated with zwitterionic poly (carboxybetaine) in undiluted blood serum. Biomaterials 30:5617–5621
Rosen JE, Gu FX (2011) Surface functionalization of silica nanoparticles with cysteine: a low-fouling zwitterionic surface. Langmuir 27:10507–10513
Murthy AK, Stover RJ, Hardin WG et al (2013) Charged gold nanoparticles with essentially zero serum protein adsorption in undiluted fetal bovine serum. JACS 135:7799–7802
Moyano DF, Saha K, Prakash G et al (2014) Fabrication of corona-free nanoparticles with tunable hydrophobicity. ACS Nano 8:6748–6755
Acknowledgements
SMA acknowledges Council for Scientific and Industrial Research (CSIR) for the research associate fellowship. CMR acknowledges the Department of Science and Technology, India for Sir J.C. Bose Fellowship. MFA acknowledges Dr. Chris Dealwis and NIH for supporting Postdoctoral/Senior Research associate fellowship. Also, we would like to thank Uzma Nisar for proofreading.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Ahsan, S.M., Rao, C.M., Ahmad, M.F. (2018). Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona. In: Saquib, Q., Faisal, M., Al-Khedhairy, A., Alatar, A. (eds) Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology, vol 1048. Springer, Cham. https://doi.org/10.1007/978-3-319-72041-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-72041-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72040-1
Online ISBN: 978-3-319-72041-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)